Efmoroctocog Alfa
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB11607 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 78 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | pseudo-von Willebrand disease | KG + DL |
| 2 | primary release disorder of platelets | KG + DL |
| 3 | Glanzmann thrombasthenia | KG + DL |
| 4 | Scott syndrome | KG + DL |
| 5 | acquired coagulation factor deficiency | KG + DL |
| 6 | bleeding diathesis due to a collagen receptor defect | KG + DL |
| 7 | hemorrhagic disorder due to a constitutional thrombocytopenia | KG + DL |
| 8 | fetal and neonatal alloimmune thrombocytopenia | KG + DL |
| 9 | hemophilia A with vascular abnormality | KG + DL |
| 10 | thrombotic thrombocytopenic purpura | KG + DL |
| 11 | platelet-type bleeding disorder | KG + DL |
| 12 | factor XI deficiency | KG + DL |
| 13 | Ehlers-Danlos syndrome, fibronectinemic type | KG + DL |
| 14 | flood factor deficiency | KG + DL |
| 15 | methylcobalamin deficiency type cblG | KG + DL |
| 16 | familial thrombomodulin anomalies | KG + DL |
| 17 | hereditary thrombocytosis with transverse limb defect | KG + DL |
| 18 | hemorrhagic disorder due to a platelet anomaly | KG + DL |
| 19 | prothrombin deficiency | KG + DL |
| 20 | acquired hemophilia | KG + DL |
| 21 | inherited thrombophilia | KG + DL |
| 22 | congenital factor XIII deficiency | KG + DL |
| 23 | congenital factor V deficiency | KG + DL |
| 24 | factor XIII, A subunit, deficiency | KG + DL |
| 25 | factor X deficiency | KG + DL |
| 26 | congenital Horner syndrome (disease) | KG + DL |
| 27 | camptodactyly, myopia, and fibrosis of the medial rectus muscle of eye | KG + DL |
| 28 | ptosis-strabismus-ectopic pupils syndrome | KG + DL |
| 29 | jaw-winking syndrome | KG + DL |
| 30 | ptosis-vocal cord paralysis syndrome | KG + DL |
| 31 | epiblepharon | KG + DL |
| 32 | Tatsumi factor deficiency | KG + DL |
| 33 | factor VII deficiency | KG + DL |
| 34 | congenital entropion | KG + DL |
| 35 | ptosis-upper ocular movement limitation-absence of lacrimal punctum syndrome | KG + DL |
| 36 | congenital ectropion | KG + DL |
| 37 | congenital plasminogen activator inhibitor type 1 deficiency | KG + DL |
| 38 | multiple sclerosis-ichthyosis-factor VIII deficiency syndrome | KG + DL |
| 39 | factor XIII deficiency | KG + DL |
| 40 | hypoplasminogenemia | KG + DL |
| 41 | mucopolysaccharidosis | KG + DL |
| 42 | esophageal varices without bleeding | KG + DL |
| 43 | esophageal varices with bleeding | KG + DL |
| 44 | inherited prekallikrein deficiency | KG + DL |
| 45 | hemorrhagic disorder due to a coagulation factors defect | KG + DL |
| 46 | varicose disease | KG + DL |
| 47 | Peyronie disease | KG + DL |
| 48 | autosomal dominant macrothrombocytopenia | KG + DL |
| 49 | von Willebrand disease (hereditary or acquired) | KG + DL |
| 50 | congenital factor XI deficiency | KG + DL |
(Showing top 50 of 78 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.